SGLT-2 inhibitors provide morbidity and mortality benefits for patients with heart failure
1. SGLT-2 inhibitors reduced time to first hospitalization and cardiovascular death among patients with preserved, mildly reduced, and reduced ejection ...
Tag: cardiovascular mortality
Empaglifozin reduces death in heart failure patients with preserved ejection fraction
1. Empaglifozin treatment was shown to have reduced rates of cardiovascular death or hospitalization in patients with heart failure and ...
De-escalation with clopidogrel may reduce bleeding events in patients with recent percutaneous coronary intervention
1. 12-months after randomization, the de-escalation group met the criteria for superiority (p=0.0001) with respect to the composite primary outcome ...
Long-term enzyme-inducing antiseizure medication use associated with elevated hazard of incident cardiovascular disease
1. In this cohort study, there was a dose-dependent association between enzyme-inducing antiseizure medication use and an elevated hazard of ...
Fixed-dose combination treatment with aspirin may reduce the risk of cardiovascular disease
1. Risk of cardiovascular death, myocardial infarction, stroke, and revascularization was lower in the fixed-dose combination pill group compared to ...
Association of sleep duration with all-cause mortality in East Asian adults
1. Sleep duration, when adjusted for body mass index (BMI), had an association with all-cause mortality at lower and higher ...
Cycling is associated with reduced all-cause and cardiovascular disease mortality in individuals with diabetes
1. Time spent cycling was associated with lower all-cause and cardiovascular disease-specific mortality in this multicenter European cohort study of ...
Bariatric surgery associated with improvement in macrovascular and microvascular function across subgroups of patients with obesity and cardiovascular risk
1. Weight loss surgery was associated with significant improvement in both macrovascular and microvascular function across subgroups of sex, race, ...
Clopidogrel monotherapy is superior to aspirin monotherapy for chronic maintenance after percutaneous coronary intervention
1. Clopidogrel monotherapy reduced long-term rates of all-cause mortality, non-fatal myocardial infarction, and stroke after drug-eluting stent placement compared with ...
